Old Web
English
Sign In
Acemap
>
authorDetail
>
Maurizio Cantore
Maurizio Cantore
Vita-Salute San Raffaele University
Oxaliplatin
Medicine
Adjuvant therapy
Colorectal cancer
Gastroenterology
3
Papers
104
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
2018
Journal of Clinical Oncology
Alberto Sobrero
Sara Lonardi
Gerardo Rosati
Maria Di Bartolomeo
M. Ronzoni
Nicoletta Pella
Mario Scartozzi
Maria Banzi
Maria Zampino
Felice Pasini
Paolo Marchetti
Maurizio Cantore
Alberto Zaniboni
Lorenza Rimassa
L. Ciuffreda
D. Ferrari
Vittorina Zagonel
Evaristo Maiello
S. Barni
Eliana Rulli
Roberto Labianca
Show All
Source
Cite
Save
Citations (43)
FOLFOX4/XELOX in stage II–III colon cancer: Efficacy results of the Italian three or six colon adjuvant (TOSCA) trial.
2017
Journal of Clinical Oncology
A. Sobrero
Sara Lonardi
Gerardo Rosati
Maria Di Bartolomeo
M. Ronzoni
Nicoletta Pella
Mario Scartozzi
Maria Banzi
M. Giulia Zampino
Felice Pasini
Paolo Marchetti
Maurizio Cantore
Alberto Zaniboni
Lorenza Rimassa
Libero Ciuffreda
Daris Ferrari
Vittorina Zagonel
Evaristo Maiello
Eliana Rulli
Roberto Labianca
Show All
Source
Cite
Save
Citations (4)
GemOx (Gemcitabine + Oxaliplatin) versus Gem (Gemcitabine) in non resectable pancreatic adenocarcinoma : final results of the GERCOR /GISCAD Intergroup Phase III
2004
Journal of Clinical Oncology
C. Louvet
R. Labianca
P. Hammel
Gérard Lledo
F. de Braud
T. André
Maurizio Cantore
Michel Ducreux
Alberto Zaniboni
A. de Gramont
Show All
Source
Cite
Save
Citations (57)
1